Literature DB >> 35415410

On Comprehensive Mass Spectrometry Data Analysis for Proteome Profiling of Human Blood Samples.

Sameer Manchanda1, Mikaela Meyer2, Qianqian Li3, Kai Liang3, Yan Li3, Nan Kong4.   

Abstract

To guarantee meaningful interpretation of data in basic and translational medicine, it is critical to ensure the quality of biological samples. Mass spectrometers have become promising instruments to acquire proteomic information that is known to be associated with the quality of samples. However, a universally applicable mass spectrometry data analysis platform for quality assessment remains of great need. We present a comprehensive pattern recognition study to facilitate the development of such a platform. This study involves feature extraction, binary classification, and feature ranking. In this study, we develop classifiers with classification accuracy higher than 90% in distinguishing human serum samples stored for different amounts of time. We also derive fingerprint patterns of serum peptides that can be conveniently used for temporal classification. © Springer International Publishing AG, part of Springer Nature 2018.

Entities:  

Keywords:  Binary classification; Blood sample; Feature ranking; Mass spectrometry; Proteome profiling

Year:  2018        PMID: 35415410      PMCID: PMC8982741          DOI: 10.1007/s41666-018-0022-0

Source DB:  PubMed          Journal:  J Healthc Inform Res        ISSN: 2509-498X


  25 in total

1.  Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data.

Authors:  J S Yu; S Ongarello; R Fiedler; X W Chen; G Toffolo; C Cobelli; Z Trajanoski
Journal:  Bioinformatics       Date:  2005-03-22       Impact factor: 6.937

2.  HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.

Authors:  Alex J Rai; Craig A Gelfand; Bruce C Haywood; David J Warunek; Jizu Yi; Mark D Schuchard; Richard J Mehigh; Steven L Cockrill; Graham B I Scott; Harald Tammen; Peter Schulz-Knappe; David W Speicher; Frank Vitzthum; Brian B Haab; Gerard Siest; Daniel W Chan
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

3.  Protocols for disease classification from mass spectrometry data.

Authors:  Michael Wagner; Dayanand Naik; Alex Pothen
Journal:  Proteomics       Date:  2003-09       Impact factor: 3.984

4.  Identifying differences in protein expression levels by spectral counting and feature selection.

Authors:  P C Carvalho; J Hewel; V C Barbosa; J R Yates
Journal:  Genet Mol Res       Date:  2008-04-15

5.  Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.

Authors:  Damiana Pieragostino; Francesca Petrucci; Piero Del Boccio; Dante Mantini; Alessandra Lugaresi; Sara Tiberio; Marco Onofrj; Domenico Gambi; Paolo Sacchetta; Carmine Di Ilio; Giorgio Federici; Andrea Urbani
Journal:  J Proteomics       Date:  2009-08-08       Impact factor: 4.044

6.  Correcting common errors in identifying cancer-specific serum peptide signatures.

Authors:  Josep Villanueva; John Philip; Carlos A Chaparro; Yongbiao Li; Ricardo Toledo-Crow; Lin DeNoyer; Martin Fleisher; Richard J Robbins; Paul Tempst
Journal:  J Proteome Res       Date:  2005 Jul-Aug       Impact factor: 4.466

7.  An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers.

Authors:  G Ball; S Mian; F Holding; R O Allibone; J Lowe; S Ali; G Li; S McCardle; I O Ellis; C Creaser; R C Rees
Journal:  Bioinformatics       Date:  2002-03       Impact factor: 6.937

8.  Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons.

Authors:  Yonggwan Won; Ho-Jun Song; Taek Won Kang; Jung-Ja Kim; Byoung-Don Han; Seung-Won Lee
Journal:  Proteomics       Date:  2003-12       Impact factor: 3.984

9.  Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data.

Authors:  Baolin Wu; Tom Abbott; David Fishman; Walter McMurray; Gil Mor; Kathryn Stone; David Ward; Kenneth Williams; Hongyu Zhao
Journal:  Bioinformatics       Date:  2003-09-01       Impact factor: 6.937

10.  A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.

Authors:  Yutaka Yasui; Margaret Pepe; Mary Lou Thompson; Bao-Ling Adam; George L Wright; Yinsheng Qu; John D Potter; Marcy Winget; Mark Thornquist; Ziding Feng
Journal:  Biostatistics       Date:  2003-07       Impact factor: 5.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.